Merck KGaA (FRA:MRK) has been assigned a €110.00 ($127.91) target price by analysts at Goldman Sachs Group, Inc. (The) in a research report issued on Thursday. The firm currently has a “neutral” rating on the healthcare company’s stock.

MRK has been the topic of several other research reports. S&P Global set a €115.00 ($133.72) price objective on shares of Merck KGaA and gave the company a “neutral” rating in a research report on Friday, May 19th. Credit Suisse Group set a €125.00 ($145.35) price objective on shares of Merck KGaA and gave the company a “buy” rating in a research report on Monday, May 8th. Warburg Research set a €116.00 ($134.88) price objective on shares of Merck KGaA and gave the company a “neutral” rating in a research report on Tuesday, June 20th. Deutsche Bank AG set a €106.00 ($123.26) price objective on shares of Merck KGaA and gave the company a “neutral” rating in a research report on Wednesday. Finally, Morgan Stanley set a €103.00 ($119.77) price objective on shares of Merck KGaA and gave the company a “neutral” rating in a research report on Monday, May 29th. Two analysts have rated the stock with a sell rating, sixteen have given a hold rating and five have given a buy rating to the company’s stock. Merck KGaA has a consensus rating of “Hold” and an average target price of €109.55 ($127.38).

Merck KGaA (FRA MRK) traded down 1.495% during midday trading on Thursday, hitting €93.875. 1,588 shares of the stock traded hands. The stock has a market capitalization of €40.76 billion and a P/E ratio of 26.171. Merck KGaA has a 52 week low of €89.00 and a 52 week high of €115.00. The stock’s 50-day moving average price is €104.78 and its 200-day moving average price is €104.70.

COPYRIGHT VIOLATION NOTICE: This piece was posted by American Banking News and is owned by of American Banking News. If you are reading this piece on another website, it was stolen and republished in violation of United States & international copyright legislation. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2017/07/27/merck-kgaa-framrk-given-a-110-00-price-target-at-goldman-sachs-group-inc-the.html.

Merck KGaA Company Profile

.

Analyst Recommendations for Merck KGaA (FRA:MRK)

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.